This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Artenga Inc. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Sebastien Roy Fournier: Innovator in Microbubble Medical Devices
Introduction
Sebastien Roy Fournier is a notable inventor based in Lachute, Canada. He has made significant contributions to the field of medical technology, particularly in the development of microbubble medical devices. His innovative work focuses on enhancing therapeutic applications through advanced methods and devices.
Latest Patents
Fournier holds a patent for "Method and medical devices for generating and stabilizing micro- or nano-bubbles." This patent outlines systems and methods for therapeutic applications using micro-bubbles. These micro-bubbles are designed to enhance therapeutic benefits, including ultrasound-guided precision drug delivery and real-time verification. They also facilitate acoustic activation of large tumor masses and improve the retention of therapeutic agents at targeted locations. Additionally, his work includes enhancements for high-intensity focused ultrasound treatments and light activation of photodynamic drugs.
Career Highlights
Fournier is associated with Artenga Inc., where he continues to develop and refine his innovative medical technologies. His work has the potential to revolutionize treatment methods in various medical fields, particularly in oncology and drug delivery systems.
Collaborations
Fournier collaborates with talented individuals such as Philippe Joel Genereux and Junjie Gu. Their combined expertise contributes to the advancement of microbubble technology and its applications in medicine.
Conclusion
Sebastien Roy Fournier's contributions to microbubble medical devices represent a significant advancement in therapeutic technology. His innovative methods and devices have the potential to greatly enhance patient care and treatment outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile